Filter
419
Text search:
drug
import
Featured
27
119
Language
Document type
212
82
72
24
17
4
4
2
2
Countries / Regions
23
15
14
12
12
12
11
11
10
10
9
8
8
8
7
7
7
7
6
5
5
5
4
4
4
4
4
4
4
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
206
26
20
15
9
5
Toolboxes
58
30
26
25
22
19
13
11
7
7
6
5
3
3
3
2
2
2
2
1
1
1
1
Fact Book on WHO Level I and Level II monitoring indicators - To monitor the progress of efforts to improve the global medicines situation, WHO has developed a system of indicators that measure important aspects of a country’s pharmaceutical situation. Level 1 indicators measure the existence and
...
Survey of the Quality of Selected Antimalarial Medicines Circulating in Six Countries of Sub-Saharan Africa
recommended
The survey aimed at evaluating the quality of selected antimalarials in six countries of sub-Saharan Africa (Cameroon, Ethiopia, Ghana, Kenya, Nigeria and the United Republic of Tanzania). These countries have been supported by WHO to strengthen their regulatory controls o
...
Towards a Healthier Botswana
Direct acting antivirals (DAAs) have revolutionized treatment for hepatitis C. Combi-
nations of DAAs can cure infection with HCV in 12 weeks, are highly effective and
have limited side-effects. Affordability of DAAs has improved significantly, but access remains lim-
i
...
Document No. : FDA/SMC/CTD/GL-CCT/2013/01
Statutory Instrument 150 of 1991 | S.I. 150 of 1991 | Amended by S.I.’ s 298/93, 61/94, 319/94, 199/98, 256/98, 36/99, 24/2001 and 257/2002, 105 and 222 /2004
Tackling Tuberculosis in Under-Served Populations: A Resource for TB Control Boards and their partners
Harm Reduction Journal (2016) 13:28
DOI 10.1186/s12954-016-0118-x
